Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Active, not recruiting · NCT02682511 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, diffuse scleroderma, immune system disorder, limited cutaneous systemic sclerosis, skin disorder, systemic sclerosis | Active, not recruiting | Phase 2 | 2026-09-02 | NCT02682511 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cumberland Pharmaceuticals | 4 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| B. J. Government Medical College | Pune | India | 1 |
| Baylor Research Institute | Dallas | United States | 1 |
| Cleveland Clinic - Florida | Weston | United States | 1 |
| Hospital for Special Surgery | New York | United States | 106 |
| Johns Hopkins University | Baltimore | United States | 25 |
| KDH - Kokilaben Dhirubhai Ambani Hospital | Mumbai | India | 1 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| Medical University of South Carolina | Charleston | United States | 17 |
| PGIMER | Chandigarh | India | 2 |
| The Universtity of Arizona Arthrtis Center | Tucson | United States | 1 |
| Thomas Jefferson University | Philadelphia | United States | 165 |
| UCLA | Los Angeles | United States | 1 |
| University of Nebraska Medical Center | Omaha | United States | 397 |